Regeneron (NASDAQ: REGN) reported Q1 EPS of $6.60, $0.47 better than the analyst estimate of $6.13. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.76 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.